Tag: Prescription Drugs
AHA: Neurohormonal Blockade Beneficial for Patients With LVAD
At four years, survival better among patients with LVADs receiving any NHB medication at six months
Ubrogepant Superior to Placebo for Migraine Pain Relief
More participants reported pain freedom at two hours with 50-mg, 25-mg ubrogepant versus placebo
AHA: Risk for Ischemic CV Events Lower With Colchicine After MI
Risk for composite efficacy end point reduced with colchicine versus placebo after myocardial infarction
Bipartisan Bill to Curb Drug Costs Backed by White House
Senate bill does not give Medicare bargaining power but would cap out-of-pocket payments by beneficiaries
FDA Panel: Expand Use of Fish Oil Drug Vascepa
Research shows drug can reduce rates of dangerous cardiovascular events in high-risk patients
Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
Treatment Response Rates High for Seniors With Hep C Infection
Sustained virologic response rates similar for patients 65 years and older, patients younger than 65 years
AHA: Intensive BP Control May Increase Life Expectancy
Implementation of treatment according to ACC/AHA 2017 guidelines is cost-effective for high-risk
ASN: Encephalopathy Up in CKD Patients on Higher-Dose Baclofen
Risk for hospitalization with encephalopathy higher for baclofen starting dose of ≥20 versus <20 mg/day
ACR: Few Serious Infections Seen in Infants Exposed to non-TNFis, Tofacitinib
Findings observed for offspring of mothers receiving tofacitinib, non-TNFis for inflammatory disease
